BAC
Bank of America Corporation
BAC has the edge over BHF overall, supported by stronger fundamentals and stronger modeled upside.
BHF
Brighthouse Financial, Inc.
BHF trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
BHF Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| N/A | |
| N/A |
BHF's revenue and profitability are currently stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like BHF.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over BHF in the historical PE scenario, which offers more potential upside but is not a forecast.
BHF PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 1.7x | $16.67 | -62% |
| Forward | 2.4x | $44.10 | — |
| Fair | 4.4x | $43.35 | -1.7% |
| Current | 4.5x | $44.10 | — |
| Expensive | 7.2x | $70.02 | +59% |
Historical ranges are pointers, not guarantees.
BHF's PE is in its fair range at 4.5x. On analysts' estimates for next year's earnings, today's price would be 2.4x, in its cheap range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over BHF on the outlook, with more favorable earnings and revenue expectations.
BHF Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Decline | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect BHF's earnings and profitability to decline, with its revenue holding steady. However, they disagree widely on these estimates.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over BHF on earnings, with more consistent year-over-year improvement.
BHF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $18.60 | +91% |
| Q3 2026 | $9.76 | -31% |
| Q2 2026 | $12.44 | +43% |
| Q1 2026 | -$3.07 | -139% |
| Q4 2025 | $5.71 | +23% |
| Q3 2025 | $14.14 | +$34.47 |
| Q2 2025 | $8.72 | +$24.63 |
| Q1 2025 | $7.82 | +$26.86 |
| Q4 2024 | $4.64 | +$23.18 |
BHF's earnings per share have fallen from their peak: $9.76 over the past year, against $46.42 in early 2020.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over BHF on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
BHF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $853M | -53% |
| Q2 2026 | $1.6B | +86% |
| Q1 2026 | $1.5B | -36% |
| Q4 2025 | $1.7B | +40% |
| Q3 2025 | $1.8B | -10% |
| Q2 2025 | $871M | -39% |
| Q1 2025 | $2.4B | +3130% |
| Q4 2024 | $1.2B | -14% |
BHF's revenue has slid since its 2020 peak: $853M last quarter, down 53% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +15 points |
| Q2 2026 | 76% | +65 points |
| Q1 2026 | -65% | -50 points |
| Q4 2025 | 8.9% | -60 points |
| Q3 2025 | 32% | +23 points |
| Q2 2025 | 11% | +9.7 points |
| Q1 2025 | -15% | +815 points |
| Q4 2024 | 69% | +153 points |
BHF has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over BHF on cash generation, producing positive trailing cash flow while its opponent burns cash.
BHF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$476M | -507% |
| Q2 2026 | -$431M | -$430M |
| Q1 2026 | -$221M | -251% |
| Q4 2025 | -$3M | +$115M |
| Q3 2025 | $117M | +388% |
| Q2 2025 | -$1M | -100% |
| Q1 2025 | $146M | +$676M |
| Q4 2024 | -$118M | -178% |
BHF's free cash flow was −$1.1B over the past year, against $144M the year before. Free cash flow isn't a meaningful measure for financial services companies like BHF.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over BHF on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
BHF Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +41.8K shares |
| 1 year | +0.6% | +369K shares |
| 3 years | -12% | -7.9M shares |
| 5 years | -30% | -25.4M shares |
| Available history | -49% | -54.6M shares |
BHF has 58M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $43M |
| Q1 2025 | $59M |
| Q4 2024 | $60M |
BHF hasn't bought back shares in the past year.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
BHF Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
BHF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.9 | Oversold |
| Stochastic | 10.5 | Oversold |
BHF's weekly RSI is 28 (oversold) and its Stochastic is 11 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
BHF PE vs Financial Services Sector
| Metric | BHF | Sector median | Relative |
|---|---|---|---|
| PE | 4.5x | 13x | 65% below |
| PE % | 52 | 63 | 11 pts below |
BHF has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over BHF on trend strength, trading above more of its moving averages.
BHF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.0 | 6.1% below |
| 20 week MA | $53.7 | 18% below |
| 50 week MA | $59.1 | 25% below |
| 100 week MA | $56.6 | 22% below |
| 200 week MA | $52.3 | 16% below |
BHF is in a downtrend: it's below all five of its weekly moving averages, and 16% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over BHF on returns for 2026, with the stronger performance.
BHF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $39.5 | $35.4 | -10% |
| 2021 | $35.4 | $52.2 | +47% |
| 2022 | $52.2 | $51.1 | -2.1% |
| 2023 | $51.1 | $52.9 | +3.5% |
| 2024 | $52.9 | $48.2 | -8.9% |
| 2025 | $48.2 | $64.9 | +34% |
| 2026 YTD | $64.9 | $44.1 | -32% |
BHF has finished lower in three of the last six years. It's down 32% so far in 2026.